主页
市场
图表与思路
Algo
新闻
商店
经纪商
下载
经济日历
交易信号
网页端
热图
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
F
FHLC
Fidelity MSCI Health Care Index ETF
72.2
8
USD
-0.76%
版块:
金融
基础:
USD
利润货币:
USD
日范围
年范围
日变化
-0.76%
每月变动
+3.85%
6个月变化
-4.40%
年变化
+16.28%
前一天收盘价
72.8
3
Open
72.2
0
最低价
72.1
9
High
72.3
0
交易量
43
市场
US ETFs
FHLC
展开完整图表
完整图表
概览
所有持仓
热图
主要持股
Market Value
Shares
Weight %
COGT
Cogent Biosciences Inc
1.30 M
36.09 K
0.05%
VCYT
Veracyte Inc
1.30 M
34.03 K
0.05%
DNLI
Denali Therapeutics Inc
1.29 M
59.56 K
0.05%
ACAD
ACADIA Pharmaceuticals Inc
1.27 M
50.56 K
0.04%
CPRX
Catalyst Pharmaceuticals Inc
1.21 M
49.91 K
0.04%
SRRK
Scholar Rock Holding Corp
1.21 M
27.24 K
0.04%
ARQT
Arcutis Biotherapeutics Inc
1.17 M
46.31 K
0.04%
SUPN
Supernus Pharmaceuticals Inc
1.15 M
23.91 K
0.04%
TVTX
Travere Therapeutics Inc
1.14 M
36.58 K
0.04%
LQDA
Liquidia Corp
1.10 M
25.98 K
0.04%
BEAM
Beam Therapeutics Inc
1.10 M
39.67 K
0.04%
CON
Concentra Group Holdings Parent Inc
1.09 M
49.09 K
0.04%
IDYA
Ideaya Biosciences Inc
1.09 M
33.80 K
0.04%
XRAY
DENTSPLY SIRONA Inc
1.08 M
86.41 K
0.04%
TWST
Twist Bioscience Corp
1.07 M
25.96 K
0.04%
XENE
Xenon Pharmaceuticals Inc
1.02 M
24.93 K
0.04%
IMNM
Immunome Inc
995.51 K
40.44 K
0.04%
PRVA
Privia Health Group Inc
986.15 K
42.47 K
0.03%
OMCL
Omnicell Inc
966.46 K
19.93 K
0.03%
CGON
CG oncology Inc
965.68 K
18.55 K
0.03%
1
...
6
7
8
9
10
11
...
17
新闻
First Quarter Earnings: Sharpening Sector Divergence
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Medical Technology Stocks: Innovation Endures As Valuations Reset
Trump's Psychedelics Stance Reignites Sector - How Investors Can Benefit
AI And The Future Of Healthcare
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Can Forgotten Biotech Break Out?
Concerns Shift From Obsolescence To Oil